Information in these tables is updated regularly.4. Several medications are available for chemoprophylaxis. When deciding which drug to use, consider specific itinerary, length of trip, cost of drug, previous adverse reactions to antimalarials, drug allergies, and current medical history. Hydroxychloroquine brands Is there a generic for plaquenil Plaquenil and log qt Plaquenil immunosuppress Background. Chloroquine is the first-line treatment for Plasmodium vivax malaria in most endemic countries, but resistance is increasing. Monitoring of antimalarial efficacy is essential, but in P vivax infections the assessment of treatment efficacy is confounded by relapse from the dormant liver stages. Searches for new drugs against chloroquine-resistant malaria, especially as they relate to analogues of chloroquine and chemosensitizing agents against the different forms of P. falciparum and P. vivax, should benefit greatly from research work in this area Although drug resistance has forced most malaria endemic countries to abandon chloroquine treatment for P. falciparum malaria, chloroquine remains the first line treatment for P. vivax malaria. This strategy is now under threat from the emergence and spread of chloroquine resistant P. vivax 2, 6-7. This risk estimate is based largely on cases occurring in US military personnel who travel for extended periods of time with unique itineraries that likely do not reflect the risk for the average US traveler.6. All travelers should seek medical attention in the event of fever during or after return from travel to areas with malaria.5. Chloroquine resistant malaria vivax Chloroquine-resistant Plasmodium vivax in Pakistan an., Chloroquine-Resistant Malaria The Journal of Infectious. Chloroquine nursing considerationsPlaquenil interactions herbsHydroxychloroquine over the counterChloroquine syrup dosage for infants Background. Plasmodium vivax accounts for about 40% of all malaria infection in Ethiopia. Chloroquine CQ is the first line treatment for confirmed P. vivax malaria in the first report of CQ treatment failure in P. vivax was from Debre Zeit, which suggested the presence of chloroquine resistance. Chloroquine-resistant Plasmodium vivax malaria in Debre.. Plasmodium vivax and drug resistance Worldwide Antimalarial.. Chloroquine-resistant Plasmodium vivax malaria in Serbo town.. Treatment of P. vivax infections. P. vivax infections should be treated with an ACT or chloroquine in areas without chloroquine-resistant P. areas where chloroquine-resistant P. vivax has been identified, infections should be treated with an ACT, preferably one in which the partner medicine has a long half-life. In Pakistan, Plasmodium vivax contributes to major malaria burden. In this case, a pregnant woman presented with P. vivax infection and which was not cleared by chloroquine, despite adequate treatment. This is probably the first confirmed case of chloroquine-resistant vivax from Pakistan, where severe malaria due to P. vivax is already an emerging problem. Chloroquine is a medication used to prevent and to treat malaria in areas where malaria is known to be sensitive to its effects. Certain types of malaria, resistant strains, and complicated cases typically require different or additional medication.